Nevertheless, results shown here depicted a new layer of regulation in control of tumor glutamine metabolism and provided a molecular explanation for the functional significance of GLS2 overexpression observed in MYCN-amplified neuroblastomas. This evidence concerns the gene GLS2 and neoplasm.